Skip to content

Role of shubhdeep kidney carepill in the treatment of Urinary tract infection

"To Evaluate The effect of Shubhdeep Kidney Care Pill in The Management of mutrakrichhra W.S.R. to UTI".

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/10/037643
Enrollment
30
Registered
2021-10-28
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N390- Urinary tract infection, site notspecified

Interventions

Intervention1: Shubhdeep kidney care pill: 500mg BID with water Intervention2: nil: nil Intervention3: SHUBHDEEP KIDNEY CARE PILL: 500 mg bid for 30 days Control Intervention1: nil: nil Control Inter

Sponsors

Dr Shruti Sharma
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1)Patients presenting with clinical features of Urinary tract infection 2)Patients between the age group of 20-50 years will be selected with irrespective of gender 3)Both new and old patient of mutrakricchra (UTI)are included in this study 4)Patient is having painful micturation 5) Burning sensation in urine .

Exclusion criteria

Exclusion criteria: 1)Patient age below 20 years and above 50 years 2)Renal failure, severe hydro nephrosis, pyonephrosis, renal tumours, renal calculi and renal abscess,septicaemia 3)Co morbidity of obstructive disease like urethral stricture,post urethral, CA prostate, bladder neck Contricture, BPH 4)Vesico-uretric reflux (in childhood). 5)AIDS, STD (sexually transmitted diseases). 6)Neurogenic bladder,granulocytopenia,solid organ transplant 7)Pregnant and lactating women. 8)TB, Carcinoma, diabetes mellitus, CCF will be excluded.

Design outcomes

Primary

MeasureTime frame
1)relief in painful micturition 2)Relief in frequency of urine 3)Relief in burning micturition 4)Relief in difficulty in micturition 5)relief in urine discoluration 6)relief in suprapubic painTimepoint: 30 days

Secondary

MeasureTime frame
nilTimepoint: nil

Countries

India

Contacts

Public ContactDr AK Singh

Shubhdeep ayurved medical college Indore

doctoraksingh@yahoo.com9300681233

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026